-+ 0.00%
-+ 0.00%
-+ 0.00%

Mstone Partners Healthcare reports USD 360,000 Polaryx Therapeutics common share purchase

PUBT·05/29/2026 00:01:20
Listen to the news
Mstone Partners Healthcare reports USD 360,000 Polaryx Therapeutics common share purchase
  • Polaryx Therapeutics disclosed an increase in beneficial ownership tied to Mstone Partners Healthcare, which bought 88,453 common shares at USD 4.07.
  • Alex Keun Mo Yang, chief executive officer, was listed as an indirect beneficial owner through Mstone Partners Healthcare.
  • The filing showed 24,233,249 common shares beneficially owned following the purchase.
  • The transaction value was USD 360,000 in gross proceeds to the issuer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polaryx Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-062322), on May 28, 2026, and is solely responsible for the information contained therein.